This week, Amplexor experts Agnes Cwienczek and David Gwyn will present at the virtual Global Pharmaceutical Regulatory Affairs Summit, which aims to show how to achieve IDMP compliance, enrich the overall global compliance strategy and incorporate business benefits. Together, they will explore how the recently published IDMP Implementation Guide v2 will impact on the life sciences industry. This long-anticipated event starts the clock for the implementation of the product and substance data submission iteration 1 timelines in the EU. But what does it mean to companies and what must be considered? How can we be certain we are IDMP-ready?
The webinar will conclude with a demonstration of practical examples of how the Amplexor Life Sciences Suite is supporting companies on their IDMP implementation journey.